Literature DB >> 14506021

Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods.

L M Best1, D J M Haldane, M Keelan, D E Taylor, A B R Thomson, V Loo, C A Fallone, P Lyn, F M Smaill, R Hunt, C Gaudreau, J Kennedy, M Alfa, R Pelletier, S J O Veldhuyzen Van Zanten.   

Abstract

Susceptibility testing was performed at seven Canadian microbiology laboratories and the Helicobacter Reference Laboratory, Halifax, Nova Scotia, Canada, to assess susceptibility testing proficiency and the reproducibility of the results for clarithromycin and metronidazole and to compare the Epsilometer test (E test) method to the agar dilution reference method. Control strain Helicobacter pylori ATCC 43504 (American Type Culture Collection) and 13 clinical isolates (plus duplicates of four of these strains including ATCC 43504) were tested blindly. The National Committee for Clinical Laboratory Standards (NCCLS) guidelines for agar dilution testing were followed, and the same suspension of organisms was used for agar dilution and E test. Antimicrobials and E test strips were provided to the investigators. Methods were provided on a website (www.Helicobactercanada.org). Each center reported MICs within the stated range for strain ATCC 43504. Compared to the average MICs, interlaboratory agreements within 2 log(2) dilutions were 90% (range, 69 to 100%) for clarithromycin by agar dilution, with seven very major errors [VMEs], and 85% (range, 65 to 100%) by E test, with three VMEs. Interlaboratory agreements within 2 log(2) dilutions were 83% (range, 50 to 100%) for metronidazole by agar dilution, with six VMEs and eight major errors (MEs), and 75% (range, 50 to 94%) by E test, with four VMEs and four MEs. At lower and higher concentrations of antibiotic, E test MICs were slightly different from agar dilution MICs, but these differences did not result in errors. When a standardized protocol based on NCCLS guidelines was used, most participants in this study correctly identified clarithromycin- and metronidazole-susceptible and -resistant strains of H. pylori 93% of the time by either the agar dilution or E test method, and the numbers of errors were relatively equivalent by both methods.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14506021      PMCID: PMC201128          DOI: 10.1128/AAC.47.10.3138-3144.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  48 in total

1.  Does helicobacter pylori eradication prevent gastric cancer?

Authors:  C A Fallone; A N Barkun; E Halwani
Journal:  Dig Liver Dis       Date:  2001-12       Impact factor: 4.088

2.  Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.

Authors:  Y Glupczynski; N Broutet; A Cantagrel; L P Andersen; T Alarcon; M López-Brea; F Mégraud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-06-28       Impact factor: 3.267

3.  Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.

Authors:  R Piccolomini; G Di Bonaventura; G Catamo; F Carbone; M Neri
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

4.  Validation of diffusion methods for macrolide susceptibility testing of Helicobacter pylori.

Authors:  B Grignon; J Tankovic; F Mégraud; Y Glupczynski; M O Husson; M C Conroy; J P Emond; J Loulergue; J Raymond; J L Fauchère
Journal:  Microb Drug Resist       Date:  2002       Impact factor: 3.431

5.  Helicobacter pylori: primary susceptibility to clarithromycin in vitro in Nova Scotia.

Authors:  L M Best; D J Haldane; G S Bezanson; S J Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  1997 May-Jun       Impact factor: 3.522

Review 6.  Long-term follow-up of gastric MALT lymphoma after H. pylori eradication.

Authors:  A Morgner; C Thiede; E Bayerdörffer; B Alpen; T Wündisch; A Neubauer; M Stolte
Journal:  Curr Gastroenterol Rep       Date:  2001-12

7.  Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease.

Authors:  Abraham M Y Nomura; Guillermo I Pérez-Pérez; James Lee; Grant Stemmermann; Martin J Blaser
Journal:  Am J Epidemiol       Date:  2002-06-01       Impact factor: 4.897

8.  Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting?

Authors:  David I Grove; George Koutsouridis
Journal:  Pathology       Date:  2002-02       Impact factor: 5.306

9.  Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.

Authors:  Joette M Meyer; Nancy P Silliman; Wenjin Wang; Nancy Y Siepman; Jennifer E Sugg; David Morris; Jie Zhang; Helen Bhattacharyya; Eileen C King; Robert J Hopkins
Journal:  Ann Intern Med       Date:  2002-01-01       Impact factor: 25.391

10.  Metronidazole susceptibility testing of Helicobacter pylori with the PDM epsilometer test (E test).

Authors:  G von Recklinghausen; R Ansorg
Journal:  Zentralbl Bakteriol       Date:  1995-01
View more
  11 in total

1.  Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.

Authors:  Sander Veldhuyzen van Zanten; Snehal Desai; Linda Best; Geraldine Cooper-Lesins; Dickran Malatjalian; David Haldane; Kevork Peltekian
Journal:  Can J Gastroenterol       Date:  2010-05       Impact factor: 3.522

2.  Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections.

Authors:  Julie M Morris; Alisa L Reasonover; Michael G Bruce; Dana L Bruden; Brian J McMahon; Frank D Sacco; Douglas E Berg; Alan J Parkinson
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

3.  Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.

Authors:  Shohreh Farshad; Abdolvahab Alborzi; Aziz Japoni; Reza Ranjbar; Kazem Hosseini Asl; Parisa Badiee; Maneli Amin Shahidi; Marziyeh Hosseini
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

4.  Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey.

Authors:  Murat Erkut; Doğan Yusuf Uzun; Neşe Kaklıkkaya; Sami Fidan; Yaşar Yoğun; Arif Mansur Coşar; Esma Akyıldız; Murat Topbaş; Orhan Özgür; Mehmet Arslan
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

5.  Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.

Authors:  Laura Cerqueira; Ricardo M Fernandes; Rui M Ferreira; Mónica Oleastro; Fátima Carneiro; Catarina Brandão; Pedro Pimentel-Nunes; Mário Dinis-Ribeiro; Céu Figueiredo; Charles W Keevil; Maria J Vieira; Nuno F Azevedo
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

6.  Pyrosequencing assay to rapidly detect clarithromycin resistance mutations in Canadian Helicobacter pylori isolates.

Authors:  R Slinger; L Yan; F Chan; K Forward; G Cooper-Lesins; L Best; D Haldane; S Veldhuyzen van Zanten
Journal:  Can J Gastroenterol       Date:  2009-09       Impact factor: 3.522

7.  Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.

Authors:  Adalucy Alvarez; José Ignacio Moncayo; Jorge Javier Santacruz; Mario Santacoloma; Luisa Fernanda Corredor; Elizabeth Reinosa
Journal:  Antimicrob Agents Chemother       Date:  2009-06-22       Impact factor: 5.191

8.  Association of hp1181 and hp1184 Genes With the Active Efflux Phenotype in Multidrug-Resistant Isolates of Helicobacter pylori.

Authors:  Tahereh Falsafi; Azadeh Ehsani; Bahareh Attaran; Vahid Niknam
Journal:  Jundishapur J Microbiol       Date:  2016-04-20       Impact factor: 0.747

9.  Increased Antibiotic Resistance in Children with Helicobacter pylori Infection: A Retrospective Study.

Authors:  Luca Helmbold; Beniam Ghebremedhin; Aliyah Bellm; Marc A Hopkins; Stefan Wirth; Malik Aydin
Journal:  Pathogens       Date:  2022-01-27

10.  Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion.

Authors:  Silvio Kazuo Ogata; Ana Cristina Gales; Elisabete Kawakami
Journal:  Braz J Microbiol       Date:  2015-03-04       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.